Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism (SAGA)

March 3, 2021 updated by: K. Suzanne Scherf, Penn State University
The investigators hypothesize that this serious game (designed to provide a learning environment that maximizes opportunities for adolescents with autism to discover the functional utility of eye gaze) will improve sensitivity to eye gaze cues, specifically to identify gazed-at objects, and will also lead to increased social attention to faces in adolescents with autism. The investigators will test this hypothesis in a small-scale exploratory randomized control trial that will include both behavioral and eye tracking outcome measures.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • University Park, Pennsylvania, United States, 16802
        • Pennsylvania State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 14 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. parent/caregiver of an adolescent with a diagnosis of ASD,
  2. parent/caregiver and adolescent with ASD both native English speakers,
  3. adolescent with ASD aged between 10-18 years at enrollment,
  4. adolescent has normal vision and hearing with correction as indicated by parent report,
  5. adolescent is able to use a computer for the purposes of game play,
  6. adolescent scores > 80% correct (i.e., 0.5 SD less than M of TD adolescents) on online eye gaze screening task,
  7. ASD diagnosis of adolescent confirmed in lab via the Autism Diagnostic Observation Schedule,
  8. Full Scale IQ of adolescent determined to be between 70-130 on the Kaufman Brief Intelligence Test,
  9. reading ability of adolescent determined to be at least a second grade level as assessed by the Oral and Written Language Scales,
  10. adolescent is capable of cooperating with testing,
  11. parent/caregiver and adolescent both consent/assent to participate in the research.

Exclusion Criteria

  1. adolescent has had seizures within the previous two years,
  2. family lacks stable home internet,
  3. parent or adolescent refuses to consent/assent to take part in the research,
  4. adolescent is 18 and has a legal guardian, prohibiting him/her from legally consenting, or
  5. adolescent is 18 and cannot understand the consent (i.e., fails consent quiz).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computer Game

All Computer Game participants will complete:

  • online screening
  • Diagnostic and eye-tracking pre-testing
  • 2 month intervention
  • Eye-tracking post-testing
The game involves viewing subtle nonverbal behaviors of game characters for the purpose of executing their own goal-directed behavior in the game related to solving various crimes. The learning involves interpreting nonverbal cues on the animated characters, such as pointing, head turns, eye gaze cues.
No Intervention: Waitlist control

All Treatment as usual control participants will complete:

  • online screening
  • Diagnostic and eye-tracking pre-testing
  • Eye-tracking post-testing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Eye Gaze Following Task
Time Frame: 2 months
Eye tracking and accuracy
2 months
Dynamic Eye Gaze Following Task
Time Frame: 2 Months
Eye tracking and accuracy
2 Months
Social/Visual Attention Task
Time Frame: 2 Months
Eye tracking
2 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Responsiveness Scale
Time Frame: 2 months
Parents completing measure of autism-like behavior in adolescents
2 months
Social Skills Inventory System - Child version
Time Frame: 2 months
Adolescents completing measure of social skills and problem behaviors in themselves
2 months
Social Skills Inventory System - Adult version
Time Frame: 2 months
Parents completing measure of social skills and problem behaviors in adolescents
2 months
Treatment as Usual
Time Frame: 2 months
Parents reporting on social and behavioral treatments adolescents receiving in and out of school
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suzy Scherf, PhD, Penn State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

November 16, 2016

First Submitted That Met QC Criteria

November 17, 2016

First Posted (Estimate)

November 18, 2016

Study Record Updates

Last Update Posted (Actual)

March 5, 2021

Last Update Submitted That Met QC Criteria

March 3, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • R61MH110624 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The data will be shared in the NIMH National Data Archive

IPD Sharing Supporting Information Type

  • Study Protocol
  • Informed Consent Form (ICF)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe